July 2022

A listing of the individual articles included in the Jurisdiction E Medicare A News bulletin dated July 2022 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
COVID-19: New Codes for Moderna Vaccine Booster Doses
Direct Data Entry Adjust, Cancel and Claim Correction On-Demand Tutorials Available
DMEPOS Items: Medical Record Documentation
Drug Pricing Claim Hold - Resolved 05/16/22 Alert
Final Epidural Steroid Injections for Pain Management LCD and Associated Billing and Coding: Epidural Steroid Injections for Pain Management - Effective June 19, 2022
Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) (L37350) Retirement - Effective June 01, 2022
FQHC Geographic Adjustment Factor Mass Adjustments - Resolved 04/11/22 Alert
Holding Claims for Pricing Based on the July 2022 FISS Release
ICD-10 and Other Coding Revisions to NCDs - July 2021 - Revised CR12124
ICD-10 and Other Coding Revisions to NCDs-October 2022 CR12705
Implanted Spinal Neurostimulators: Document Medical Records Compliance
Interns and Residents Information System (IRIS) XML Format
July 2022 I/OCE Specifications Version 23.2 CR12759
July 2022 Quarterly ASP Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files CR12685
July 2022 Update of the Hospital Outpatient Prospective Payment System (OPPS) - Revised CR12761
July Quarterly Update for 2022 DMEPOS Fee Schedule CR12772
June 30, 2022, Credit Balance reports due July 30, 2022
Kidney Health: Help Address Disparities
Lab: Cystatin C Measurement (L37616) - R4 - Effective June 09, 2022
Lumbar Epidural Injections - Retirement
Lumbar Epidural Injections Local Coverage Determination, Associated Billing and Coding Article and Response to Comments Retirement- June 20, 2022
Manipulated, Reconstituted and/or Injectable Amniotic and Placental Derived Products - Latest Update
May is Mental Health Month
MDS FISH LCD (L37620) - R5 - Effective June 30, 2022
Medicare Cards Without Full Names
Mental Health Visits via Telecommunications for RHCs & FQHCs - Revised SE22001
MLN Connects - June 16, 2022
MLN Connects - June 2, 2022
MLN Connects - June 23, 2022
MLN Connects - June 30, 2022
MLN Connects - June 9, 2022
MLN Connects Special Edition - June 21, 2022 - Home Health and ESRD Proposed CY 2023 Payment Rules
MolDX: 4Kscore Assay - Retirement
MolDX: APC and MUTYH Gene Testing L36882 Retirement - Effective August 08, 2022
MolDX: Blood Product Molecular Antigen Typing (L38331) - R3 - Effective May 26, 2022
MolDX: BRCA1 and BRCA2 Genetic Testing L36161 Retirement - Effective August 08, 2022
MolDX: ConfirmMDx Epigenetic Molecular Assay L36327 Retirement - Effective August 08, 2022
MolDX: DecisionDx-UM (Uveal Melanoma) LCD (L37070) - R6 - Effective June 30, 2022
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease LCD Title (L36180)- R11 - Effective June 30, 2022
MolDX: Genetic Testing for Lynch Syndrome L36370 Retirement - Effective August 08, 2022
MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (L38972) Final LCD - Effective August 08, 2022
MolDX: Melanoma Risk Stratification Molecular Testing (L37750) Final LCD - Effective August 08, 2022
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (L39005) Final LCD - Effective August 08, 2022
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39001) and Associated Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - Effective June 02, 2022
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia - Published for Review and Comments
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia - Published for Review and Comments
MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (L37301) Retirement - Effective June 01, 2022
MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (L38643) - R2 - Effective June 02, 2022
NCD 210.14 Reconsideration – Screening for Lung Cancer with LDCT CR12691
Nerve Blockade for Treatment of Chronic Pain and Neuropathy - Published for Review and Comments
— 50 Items per Page
Showing 1 - 50 of 68 results.